181 related articles for article (PubMed ID: 12860014)
21. Induced natural killer-like cytotoxic function in the TCR delta-1 positive human leukemic T-cell lines.
Ariyasu T; Kimura N; Kikuchi M; Kohno K; Sugamura K; Watanabe T; Minowada J
Leukemia; 1991 Sep; 5(9):807-12. PubMed ID: 1834894
[TBL] [Abstract][Full Text] [Related]
22. Clinicopathologic and genotypic study of extranodal nasal-type natural killer/T-cell lymphoma and natural killer precursor lymphoma among Koreans.
Ko YH; Ree HJ; Kim WS; Choi WH; Moon WS; Kim SW
Cancer; 2000 Nov; 89(10):2106-16. PubMed ID: 11066052
[TBL] [Abstract][Full Text] [Related]
23. Expression of cytotoxic proteins in peripheral T-cell and natural killer-cell (NK) lymphomas: association with extranodal site, NK or Tgammadelta phenotype, anaplastic morphology and CD30 expression.
Kanavaros P; Boulland ML; Petit B; Arnulf B; Gaulard P
Leuk Lymphoma; 2000 Jul; 38(3-4):317-26. PubMed ID: 10830738
[TBL] [Abstract][Full Text] [Related]
24. Nasal natural killer/T-cell lymphoma and its association with type "i"/XhoI loss strain Epstein-Barr virus in Chile.
Cabrera ME; Eizuru Y; Itoh T; Koriyama C; Tashiro Y; Ding S; Rey S; Akiba S; Corvalan A
J Clin Pathol; 2007 Jun; 60(6):656-60. PubMed ID: 16775124
[TBL] [Abstract][Full Text] [Related]
25. Natural killer (NK) activity of cultured S100 beta-positive T-leukemia cells.
Takahashi K; Yoshino T; Akagi T; Miyatani K; Hayashi K; Sonobe H; Ohtsuki Y
Virchows Arch B Cell Pathol Incl Mol Pathol; 1990; 59(3):159-64. PubMed ID: 1980762
[TBL] [Abstract][Full Text] [Related]
26. [Natural killer-like T-cell lymphoma/leukemia--a case report and literature review].
Zhang FK; Wang HJ; Wu YH; Dong SX; Li HQ; Yang DL; Chen HS; Chu YL
Zhonghua Xue Ye Xue Za Zhi; 2006 Apr; 27(4):226-30. PubMed ID: 16875551
[TBL] [Abstract][Full Text] [Related]
27. Tofacitinib induces G1 cell-cycle arrest and inhibits tumor growth in Epstein-Barr virus-associated T and natural killer cell lymphoma cells.
Ando S; Kawada JI; Watanabe T; Suzuki M; Sato Y; Torii Y; Asai M; Goshima F; Murata T; Shimizu N; Ito Y; Kimura H
Oncotarget; 2016 Nov; 7(47):76793-76805. PubMed ID: 27732937
[TBL] [Abstract][Full Text] [Related]
28. Common cytological and cytogenetic features of Epstein-Barr virus (EBV)-positive natural killer (NK) cells and cell lines derived from patients with nasal T/NK-cell lymphomas, chronic active EBV infection and hydroa vacciniforme-like eruptions.
Zhang Y; Nagata H; Ikeuchi T; Mukai H; Oyoshi MK; Demachi A; Morio T; Wakiguchi H; Kimura N; Shimizu N; Yamamoto K
Br J Haematol; 2003 Jun; 121(5):805-14. PubMed ID: 12780797
[TBL] [Abstract][Full Text] [Related]
29. Characterization of natural killer and natural killer-like T cells derived from ex vivo expanded and activated cord blood mononuclear cells: implications for adoptive cellular immunotherapy.
Ayello J; van de Ven C; Cairo E; Hochberg J; Baxi L; Satwani P; Cairo MS
Exp Hematol; 2009 Oct; 37(10):1216-29. PubMed ID: 19638292
[TBL] [Abstract][Full Text] [Related]
30. Detection of Epstein-Barr virus genome in natural-killer-like cell line, YT.
Yoneda N; Tatsumi E; Kawano S; Teshigawara K; Oka T; Fukuda M; Yamaguchi N
Leukemia; 1992 Feb; 6(2):136-41. PubMed ID: 1313126
[TBL] [Abstract][Full Text] [Related]
31. Human invariant V alpha 24-J alpha Q TCR supports the development of CD1d-dependent NK1.1+ and NK1.1- T cells in transgenic mice.
Capone M; Cantarella D; Schümann J; Naidenko OV; Garavaglia C; Beermann F; Kronenberg M; Dellabona P; MacDonald HR; Casorati G
J Immunol; 2003 Mar; 170(5):2390-8. PubMed ID: 12594262
[TBL] [Abstract][Full Text] [Related]
32. [Clinico-pathologic forms of peripheral T-and NK-cell lymphomas].
Foss HD; Coupland SE; Stein H
Pathologe; 2000 Mar; 21(2):137-46. PubMed ID: 10840819
[TBL] [Abstract][Full Text] [Related]
33. Modulation of natural killer (NK) receptors on NK (CD3-/CD56+), T (CD3+/CD56-) and NKT-like (CD3+/CD56+) cells after heart transplantation.
Aguilar P; Mathieu CP; Clerc G; Ethevenot G; Fajraoui M; Mattei S; Faure GC; Bene MC
J Heart Lung Transplant; 2006 Feb; 25(2):200-5. PubMed ID: 16446221
[TBL] [Abstract][Full Text] [Related]
34. Human invariant valpha24+ natural killer T cells activated by alpha-galactosylceramide (KRN7000) have cytotoxic anti-tumour activity through mechanisms distinct from T cells and natural killer cells.
Nicol A; Nieda M; Koezuka Y; Porcelli S; Suzuki K; Tadokoro K; Durrant S; Juji T
Immunology; 2000 Feb; 99(2):229-34. PubMed ID: 10692041
[TBL] [Abstract][Full Text] [Related]
35. CD1d-specific NK1.1+ T cells with a transgenic variant TCR.
Sköld M; Faizunnessa NN; Wang CR; Cardell S
J Immunol; 2000 Jul; 165(1):168-74. PubMed ID: 10861049
[TBL] [Abstract][Full Text] [Related]
36. Demonstration of aberrant T-cell and natural killer-cell antigen expression in all cases of granular lymphocytic leukaemia.
Morice WG; Kurtin PJ; Leibson PJ; Tefferi A; Hanson CA
Br J Haematol; 2003 Mar; 120(6):1026-36. PubMed ID: 12648073
[TBL] [Abstract][Full Text] [Related]
37. Expansion of natural killer (NK) and natural killer-like T (NKT)-cell populations derived from patients with B-chronic lymphocytic leukemia (B-CLL): a potential source for cellular immunotherapy.
Guven H; Gilljam M; Chambers BJ; Ljunggren HG; Christensson B; Kimby E; Dilber MS
Leukemia; 2003 Oct; 17(10):1973-80. PubMed ID: 14513047
[TBL] [Abstract][Full Text] [Related]
38. Expression of interleukin-9 in nasal natural killer/T-cell lymphoma cell lines and patients.
Nagato T; Kobayashi H; Kishibe K; Takahara M; Ogino T; Ishii H; Oikawa K; Aoki N; Sato K; Kimura S; Shimizu N; Tateno M; Harabuchi Y
Clin Cancer Res; 2005 Dec; 11(23):8250-7. PubMed ID: 16322282
[TBL] [Abstract][Full Text] [Related]
39. Transcriptional profiling of Epstein-Barr virus (EBV) genes and host cellular genes in nasal NK/T-cell lymphoma and chronic active EBV infection.
Zhang Y; Ohyashiki JH; Takaku T; Shimizu N; Ohyashiki K
Br J Cancer; 2006 Feb; 94(4):599-608. PubMed ID: 16449999
[TBL] [Abstract][Full Text] [Related]
40. Hepatosplenic gammadelta T-cell lymphoma: relation to Epstein-Barr virus and activated cytotoxic molecules.
Ohshima K; Haraoka S; Harada N; Kamimura T; Suzumiya J; Kanda M; Kawasaki C; Sugihara M; Kikuchi M
Histopathology; 2000 Feb; 36(2):127-35. PubMed ID: 10672057
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
